Cornell’s Research Serves the Region and Beyond

Metabolon Inc. CTL

Health Technology

  • Products:
  • Precision metabolomics
  • Complex lipid panel
  • Targeted assays
  • Quantose IR
  • Quantose IGT
  • Meta IMD

Metabolon is the global leader in metabolomics. Its patented health technology platform provides a global analysis of metabolites in a biological sample for the discovery of biomarkers and pathways associated with drug action and disease. This metabolomics-driven approach enables the identification of biomarkers useful for the development of a wide range of diagnostics for precision medicine and provides insight into complex biochemical processes, such as drug action, toxicology, and bioprocess optimization.

Cornell Connection

A member of the Weill Cornell Medicine faculty helped develop the methodology that shaped Metabolon’s metabolomic expertise. The company's foundational technology is licensed from Cornell University.